Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
3/25/25 | Axsome Therapeutics (AXSM) | Sunosi for Attention Deficit Hyperactivity Disorder (ADHD) | Subscribers Only | Subscribers Only | Subscribers Only |
3/19/25 | Immunovant (IMVT) | Batoclimab for Myasthenia Gravis (MG) | Subscribers Only | Subscribers Only | Subscribers Only |
3/17/25 | ORCA Bio | Orca-T for Myelodysplastic Syndrome (MDS) | Subscribers Only | Subscribers Only | Subscribers Only |
3/17/25 | ORCA Bio | Orca-T for Acute Lymphoblastic Leukemia (ALL) | Subscribers Only | Subscribers Only | Subscribers Only |
3/17/25 | ORCA Bio | Orca-T for Acute Myelogenous Leukemia (AML) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
12/31/2024 | Subscribers Only | Subscribers Only | Regulatory - IND/CTA Filing |
02/12/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
02/27/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
03/24/2025 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |
03/25/2025 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |